| 33 |
Ding C，Xi G，Wang G，et al. Exosomal Circ-MEMO1 promotes the progression and aerobic glycolysis of non-small cell lung cancer through targeting MiR-101-3p/KRAS axis［J］. Front Genet，2020，11：962.
|
| 34 |
Fares J，Fares MY，Khachfe HH，et al. Molecular principles of metastasis： a hallmark of cancer revisited［J］. Signal Transduct Target Ther，2020，5（1）： 28.
|
| 35 |
Liu G，Shi H，Deng L，et al. Circular RNA circ-FOXM1 facilitates cell progression as ceRNA to target PPDPF and MACC1 by sponging miR-1304-5p in non-small cell lung cancer［J］. Biochem Biophys Res Commun，2019，513（1）： 207-212.
|
| 36 |
Hohmann T，Hohmann U，Dehghani F. MACC1-induced migration in tumors： Current state and perspective［J］. Front Oncol，2023，13： 1165676.
|
| 37 |
Li L，Li W，Chen N，et al. FLI1 exonic circular RNAs as a novel oncogenic driver to promote tumor metastasis in small cell lung cancer［J］. Clin Cancer Res，2019，25（4）： 1302-1317.
|
| 38 |
Chen T，Liu Y，Li C，et al. Tumor-derived exosomal circFARSA mediates M2 macrophage polarization via the PTEN/PI3K/AKT pathway to promote non-small cell lung cancer metastasis［J］. Cancer Treat Res Commun，2021，28： 100412.
|
| 39 |
Chen M，Cao C，Ma J. Tumor-related exosomal circ_0001715 promotes lung adenocarcinoma cell proliferation and metastasis via enhancing M2 macrophage polarization by regulating triggering receptor expressed on myeloid cells-2［J］. Thorac Cancer，2024，15（3）：227-238.
|
| 40 |
Wang R，Liu H，Dong M，et al. Exosomal hsa_circ_0000519 modulates the NSCLC cell growth and metastasis via miR-1258/RHOV axis［J］. Open Med （Wars），2022，17（1）： 826-840.
|
| 41 |
Wang D，Wang S，Jin M，et al. Hypoxic exosomal circPLEKHM1-mediated crosstalk between tumor cells and macrophages drives lung cancer metastasis ［J］. Adv Sci （ Weinh），2024，11 （22）：e2309857.
|
| 42 |
Liu S，Wu X，Wang Y，et al. Exosomal circ_0000735 contributes to non-small lung cancer malignant progression［J］. J Biochem Mol Toxicol，2024，38（4）： e23700.
|
| 43 |
Shi Q，Ji T，Ma Z，et al. Serum exosomes-based biomarker circ_0008928 regulates cisplatin sensitivity，tumor progression，and glycolysis metabolism by miR-488/HK2 axis in cisplatin-resistant nonsmall cell lung carcinoma［J］. Cancer Biother Radiopharm，2023，38（8）： 558-571.
|
| 1 |
Li Y，Yan B，He S. Advances and challenges in the treatment of lung cancer［J］. Biomed Pharmacother，2023，169：115891.
|
| 2 |
Sung H，Ferlay J，Siegel RL，et al. Global Cancer Statistics 2020：GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries［J］. CA Cancer J Clin，2021，71（3）：209-249.
|
| 3 |
Thai AA，Solomon BJ，Sequist LV，et al. Lung cancer［J］. Lancet，2021，398（10299）： 535-554.
|
| 4 |
Wu B，Liu DA，Guan L，et al. Stiff matrix induces exosome secretion to promote tumour growth［J］. Nat Cell Biol，2023，25（3）： 415-424.
|
| 5 |
Li Y，Zheng Q，Bao C，et al. Circular RNA is enriched and stable in exosomes： a promising biomarker for cancer diagnosis［J］. Cell Res，2015，25（8）： 981-984.
|
| 6 |
Liu CX，Chen LL. Circular RNAs： Characterization，cellular roles，and applications［J］. Cell，2022，185（12）： 2016-2034.
|
| 7 |
Kalluri R，Lebleu VS. The biology，function，and biomedical applications of exosomes［J］. Science，2020，367（6478）： eaau6977.
|
| 8 |
Han QF，Li WJ，Hu KS，et al. Exosome biogenesis： Machinery，regulation，and therapeutic implications in cancer［J］. Mol Cancer，2022，21（1）： 207.
|
| 9 |
Ren L，Jiang Q，Mo L，et al. Mechanisms of circular RNA degradation［J］. Commun Biol，2022，5（1）： 1355.
|
| 10 |
Vromman M，Vandesompele J，Volders PJ. Closing the circle：current state and perspectives of circular RNA databases ［ J］. Brief Bioinform，2021，22（1）： 288-297.
|
| 11 |
Liao Y，Peng X，Li X，et al. CircRNA_45478 promotes ischemic AKI by targeting the miR-190a-5p/PHLPP1 axis［J］. FASEB J，2022，36（12）： e22633.
|
| 12 |
Rossi F，Beltran M，Damizia M，et al. Circular RNA ZNF609/CKAP5 mRNA interaction regulates microtubule dynamics and tumorigenicity［J］. Mol Cell，2022，82（1）： 75-89.e79.
|
| 13 |
Cheng J，Li G，Wang W，et al. Circular RNAs with protein-coding ability in oncogenesis［J］. Biochim Biophys Acta Rev Cancer，2023，1878（4）： 188909.
|
| 14 |
Zhang Y，Zhang XO，Chen T，et al. Circular intronic long noncoding RNAs［J］. Mol Cell，2013，51（6）： 792-806.
|
| 15 |
Du WW，Yang W，Liu E，et al. Foxo3 circular RNA retards cell cycle progression via forming ternary complexes with p21 and CDK2［J］. Nucleic Acids Res，2016，44（6）： 2846-2858.
|
| 16 |
Liu N，Zhang Z，Wu Y，et al. CRBSP：Prediction of CircRNA-RBP binding sites based on multimodal intermediate fusion［J］. IEEE/ACM Trans Comput Biol Bioinform，20（5）： 2898-2906.
|
| 17 |
Fanale D，Taverna S，Russo A，et al. Circular RNA in Exosomes［J］. Adv Exp Med Biol，2018，1087：109-117.
|
| 18 |
Xu Z，Chen Y，Ma L，et al. Role of exosomal non-coding RNAs from tumor cells and tumor-associated macrophages in the tumor microenvironment［J］. Mol Ther，2022，30（10）： 3133-3154.
|
| 19 |
Zhang F，Jiang J，Qian H，et al. Exosomal circRNA： emerging insights into cancer progression and clinical application potential［J］.J Hematol Oncol，2023，16（1）： 67.
|
| 20 |
Ji J，Yang S，Zu L，et al. Deubiquitinating enzyme USP41 promotes lung cancer cell proliferation and migration［J］. Thorac Cancer，2021，12（7）： 1041-1047.
|
| 21 |
Zhang N，Nan A，Chen L，et al. Circular RNA circSATB2 promotes progression of non-small cell lung cancer cells［J］. Mol Cancer，2020，19（1）： 101.
|
| 22 |
Zhou B，Mo Z，Lai G，et al. Targeting tumor exosomal circular RNA cSERPINE2 suppresses breast cancer progression by modulating MALT1-NF-κB-IL-6 axis of tumor-associated macrophages［J］. J Exp Clin Cancer Res，2023，42（1）： 48.
|
| 23 |
Geng X，Lin X，Zhang Y，et al. Exosomal circular RNA sorting mechanisms and their function in promoting or inhibiting cancer［J］.Oncol Lett，2020，19（5）： 3369-3380.
|
| 24 |
Xu X，Tao R，Sun L，et al. Exosome-transferred hsa_circ_0014235 promotes DDP chemoresistance and deteriorates the development of non-small cell lung cancer by mediating the miR-520a-5p/CDK4 pathway［J］. Cancer Cell Int，2020，20（1）： 552.
|
| 25 |
Liu Y，Li L，Song X. Exosomal circPVT1 derived from lung cancer promotes the progression of lung cancer by targeting miR-124-3p/EZH2 axis and regulating macrophage polarization［J］. Cell Cycle，2022，21（5）： 514-530.
|
| 26 |
Zhu J，Wang F，Weng Y，et al. Exosome-delivered circSATB2 targets the miR-330-5p/PEAK1 axis to regulate proliferation，migration and invasion of lung cancer cells［J］. Thorac Cancer，2022，13（21）： 3007-3017.
|
| 27 |
Xie H，Yao J，Wang Y，et al. Exosome-transmitted circVMP1 facilitates the progression and cisplatin resistance of non-small cell lung cancer by targeting miR-524-5p-METTL3/SOX2 axis［J］. Drug Deliv，2022，29（1）： 1257-1271.
|
| 28 |
Hong W，Du K，Zhang Q，et al. Tanreqing suppresses the proliferation and migration of non-small cell lung cancer cells by mediating the inactivation of the HIF1α signaling pathway via exosomal circ-WDR78［J］. J Biomol Struct Dyn，2025，43（5）： 2491-2502.
|
| 29 |
Morana O，Wood W，Gregory CD. The apoptosis paradox in cancer［J］. Int J Mol Sci，2022，23（3）： 1328.
|
| 30 |
Cao YZ，Sun JY，Chen YX，et al. The roles of circRNAs in cancers： Perspectives from molecular functions［J］. Gene，2021，767： 145182.
|
| 31 |
Li C，Wang G，Ma X，et al. Upregulation of exosomal circPLK1 promotes the development of non-small cell lung cancer through the miR-1294/high mobility group protein A1 axis［J］. Bioengineered，2022，13（2）： 4185-4200.
|
| 32 |
Wang L，Zhang J，Xia M，et al. High mobility group A1（HMGA1）：Structure，biological function，and therapeutic potential［J］. Int J Biol Sci，2022，18（11）： 4414-4431.
|